Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: Q4QF45
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 5 |
GO:0005488 | binding | 1 | 5 |
GO:0016491 | oxidoreductase activity | 2 | 5 |
GO:0043167 | ion binding | 2 | 5 |
GO:0043169 | cation binding | 3 | 5 |
GO:0046872 | metal ion binding | 4 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 154 | 158 | PF00656 | 0.655 |
CLV_NRD_NRD_1 | 230 | 232 | PF00675 | 0.546 |
CLV_NRD_NRD_1 | 45 | 47 | PF00675 | 0.618 |
CLV_NRD_NRD_1 | 50 | 52 | PF00675 | 0.611 |
CLV_NRD_NRD_1 | 53 | 55 | PF00675 | 0.462 |
CLV_PCSK_FUR_1 | 228 | 232 | PF00082 | 0.549 |
CLV_PCSK_FUR_1 | 51 | 55 | PF00082 | 0.389 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.515 |
CLV_PCSK_KEX2_1 | 230 | 232 | PF00082 | 0.532 |
CLV_PCSK_KEX2_1 | 282 | 284 | PF00082 | 0.573 |
CLV_PCSK_KEX2_1 | 45 | 47 | PF00082 | 0.632 |
CLV_PCSK_KEX2_1 | 50 | 52 | PF00082 | 0.648 |
CLV_PCSK_KEX2_1 | 53 | 55 | PF00082 | 0.564 |
CLV_PCSK_PC1ET2_1 | 2 | 4 | PF00082 | 0.515 |
CLV_PCSK_PC1ET2_1 | 282 | 284 | PF00082 | 0.573 |
CLV_PCSK_PC7_1 | 46 | 52 | PF00082 | 0.560 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.507 |
DEG_SCF_FBW7_1 | 159 | 165 | PF00400 | 0.593 |
DOC_CKS1_1 | 159 | 164 | PF01111 | 0.637 |
DOC_CKS1_1 | 9 | 14 | PF01111 | 0.491 |
DOC_CYCLIN_yCln2_LP_2 | 9 | 15 | PF00134 | 0.485 |
DOC_MAPK_gen_1 | 50 | 61 | PF00069 | 0.507 |
DOC_MAPK_MEF2A_6 | 269 | 276 | PF00069 | 0.390 |
DOC_MAPK_MEF2A_6 | 53 | 61 | PF00069 | 0.440 |
DOC_MAPK_NFAT4_5 | 54 | 62 | PF00069 | 0.492 |
DOC_SPAK_OSR1_1 | 269 | 273 | PF12202 | 0.494 |
DOC_USP7_MATH_1 | 100 | 104 | PF00917 | 0.497 |
DOC_USP7_MATH_1 | 126 | 130 | PF00917 | 0.542 |
DOC_USP7_MATH_1 | 162 | 166 | PF00917 | 0.670 |
DOC_USP7_MATH_1 | 286 | 290 | PF00917 | 0.641 |
DOC_WW_Pin1_4 | 158 | 163 | PF00397 | 0.651 |
DOC_WW_Pin1_4 | 174 | 179 | PF00397 | 0.796 |
DOC_WW_Pin1_4 | 234 | 239 | PF00397 | 0.739 |
DOC_WW_Pin1_4 | 242 | 247 | PF00397 | 0.724 |
DOC_WW_Pin1_4 | 296 | 301 | PF00397 | 0.740 |
DOC_WW_Pin1_4 | 34 | 39 | PF00397 | 0.523 |
DOC_WW_Pin1_4 | 8 | 13 | PF00397 | 0.580 |
LIG_14-3-3_CanoR_1 | 116 | 120 | PF00244 | 0.449 |
LIG_14-3-3_CanoR_1 | 3 | 12 | PF00244 | 0.455 |
LIG_BRCT_BRCA1_1 | 264 | 268 | PF00533 | 0.653 |
LIG_FHA_1 | 139 | 145 | PF00498 | 0.396 |
LIG_FHA_1 | 154 | 160 | PF00498 | 0.533 |
LIG_FHA_1 | 4 | 10 | PF00498 | 0.525 |
LIG_FHA_2 | 67 | 73 | PF00498 | 0.456 |
LIG_FHA_2 | 9 | 15 | PF00498 | 0.567 |
LIG_LIR_Gen_1 | 69 | 78 | PF02991 | 0.461 |
LIG_LIR_Nem_3 | 69 | 74 | PF02991 | 0.456 |
LIG_PDZ_Class_1 | 299 | 304 | PF00595 | 0.681 |
LIG_SH2_STAP1 | 86 | 90 | PF00017 | 0.492 |
LIG_SH2_STAP1 | 92 | 96 | PF00017 | 0.502 |
LIG_SH3_3 | 156 | 162 | PF00018 | 0.671 |
LIG_SH3_3 | 172 | 178 | PF00018 | 0.726 |
LIG_SH3_3 | 35 | 41 | PF00018 | 0.577 |
MOD_CDK_SPK_2 | 234 | 239 | PF00069 | 0.627 |
MOD_CK1_1 | 176 | 182 | PF00069 | 0.781 |
MOD_CK1_1 | 289 | 295 | PF00069 | 0.712 |
MOD_CK1_1 | 296 | 302 | PF00069 | 0.713 |
MOD_CK1_1 | 33 | 39 | PF00069 | 0.580 |
MOD_CK2_1 | 66 | 72 | PF00069 | 0.465 |
MOD_CK2_1 | 8 | 14 | PF00069 | 0.539 |
MOD_GlcNHglycan | 103 | 106 | PF01048 | 0.622 |
MOD_GlcNHglycan | 128 | 131 | PF01048 | 0.530 |
MOD_GlcNHglycan | 146 | 149 | PF01048 | 0.316 |
MOD_GlcNHglycan | 164 | 167 | PF01048 | 0.540 |
MOD_GlcNHglycan | 217 | 220 | PF01048 | 0.505 |
MOD_GlcNHglycan | 264 | 267 | PF01048 | 0.580 |
MOD_GlcNHglycan | 288 | 291 | PF01048 | 0.589 |
MOD_GlcNHglycan | 295 | 298 | PF01048 | 0.571 |
MOD_GlcNHglycan | 32 | 35 | PF01048 | 0.666 |
MOD_GSK3_1 | 158 | 165 | PF00069 | 0.701 |
MOD_GSK3_1 | 173 | 180 | PF00069 | 0.706 |
MOD_GSK3_1 | 184 | 191 | PF00069 | 0.405 |
MOD_GSK3_1 | 28 | 35 | PF00069 | 0.578 |
MOD_GSK3_1 | 285 | 292 | PF00069 | 0.587 |
MOD_GSK3_1 | 295 | 302 | PF00069 | 0.701 |
MOD_NEK2_1 | 144 | 149 | PF00069 | 0.444 |
MOD_NEK2_1 | 151 | 156 | PF00069 | 0.446 |
MOD_PIKK_1 | 289 | 295 | PF00454 | 0.495 |
MOD_PKA_2 | 115 | 121 | PF00069 | 0.524 |
MOD_Plk_2-3 | 66 | 72 | PF00069 | 0.465 |
MOD_Plk_4 | 115 | 121 | PF00069 | 0.481 |
MOD_Plk_4 | 66 | 72 | PF00069 | 0.555 |
MOD_ProDKin_1 | 158 | 164 | PF00069 | 0.652 |
MOD_ProDKin_1 | 174 | 180 | PF00069 | 0.793 |
MOD_ProDKin_1 | 234 | 240 | PF00069 | 0.745 |
MOD_ProDKin_1 | 242 | 248 | PF00069 | 0.723 |
MOD_ProDKin_1 | 296 | 302 | PF00069 | 0.736 |
MOD_ProDKin_1 | 34 | 40 | PF00069 | 0.518 |
MOD_ProDKin_1 | 8 | 14 | PF00069 | 0.580 |
TRG_DiLeu_BaLyEn_6 | 76 | 81 | PF01217 | 0.425 |
TRG_ENDOCYTIC_2 | 71 | 74 | PF00928 | 0.508 |
TRG_ER_diArg_1 | 228 | 231 | PF00400 | 0.539 |
TRG_ER_diArg_1 | 50 | 53 | PF00400 | 0.618 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1ILL8 | Leptomonas seymouri | 52% | 90% |
A0A0S4JQ23 | Bodo saltans | 30% | 98% |
A0A3R7RI28 | Trypanosoma rangeli | 33% | 100% |
A0A3S7WTT4 | Leishmania donovani | 91% | 100% |
A4H8A3 | Leishmania braziliensis | 73% | 91% |
A4HWM3 | Leishmania infantum | 91% | 100% |
C9ZXR4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
E9AQD0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 100% |